I found a letter to the editor from biotech executive Mark Warner in the Wall Street Journal thought-provoking:
Your report “Boston’s Biotech Engine Is Sputtering” (U.S. News, Dec. 30) rightly notes that highly trained Ph.D.s are struggling to find work as Boston’s biotech sector contracts. But the problem isn’t an oversupply of scientists or a temporary venture-capital cycle. It’s a deeper structural failure in how the country builds industries.
The U.S. excels at funding discovery and celebrating breakthroughs, then neglects the hard work of manufacturing them at scale. When commercialization stalls, capital retreats, companies collapse and top talent is left without a place to apply its skills. We have seen this before in semiconductors, solar energy and nuclear power. Research leadership remained but manufacturing—and economic strength—moved elsewhere.
Biotechnology faces the same risk. The real bottleneck isn’t the lab; it is the lack of domestic biomanufacturing capacity to carry innovations across the “valley of death” from proof-of-concept to commercial reality. That gap is where today’s job losses are felt most acutely.
Warner correctly identifies a structural failure, but his causal chain is backwards. There is a practical, organic progression. When production moves elsewhere so does production engineering. Production engineering follows production. Design engineering follows production engineering. Research follows design engineering. What remains behind is not an innovation ecosystem but an academic one, unmoored from economic realities. There is always a lag, because engineering capability takes time to migrate. But it always migrates to where production actually occurs. As Mr. Warner himself notes, this pattern has already played out in semiconductors, solar energy, and nuclear power.
For some time we have been operating under the fantasy that the United States economy can thrive as a service economy on the basis of services, tertiary production, and retail alone, leaving the messy and energy-intensive production to other countries, preferably countries far, far away. That is a pleasant fantasy but it is a fantasy. The reality is that is the path to poverty which Mr. Warner’s letter highlights. You can export production for a while and still pretend to be an industrial power. You cannot do it indefinitely and remain one.






